The autophagy-lysosomal pathway (ALP) is involved in the degradation of longlived proteins. Deficits in the ALP result in protein aggregation, the generation of toxic protein species, and accumulation of dysfunctional organelles, which are hallmarks of Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and prion disease. Decades of research have therefore focused on enhancing the ALP in neurodegenerative diseases. More recently, transcription factor EB (TFEB), a major regulator of autophagy and lysosomal biogenesis, has emerged as a leading factor in addressing disease pathology. We review the regulation of the ALP and TFEB and their impact on neurodegenerative diseases. We also offer our perspective on the complex role of autophagy and TFEB in disease pathogenesis and its therapeutic implications through the examination of prion disease.
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Subtypes and Machinery of Autophagy
Autophagy or autophagocytosis is derived from the Greek words auto, 'self', and phagein, 'to eat'. This so-called self-eating refers to a basic catabolic mechanism/degradation pathway that involves the delivery of cytoplasmic cargo to the lysosome. Autophagy is typically categorized into three groups based on the particular physiological role of the process, the mode of cargo delivery, and the pathway. These groups are as follows: macroautophagy (see Glossary; herein referred to as autophagy), chaperone-mediated autophagy, and microautophagy. Despite mechanistic differences between the three groups, all are induced by similar stimuli such as environmental stress, nutrient starvation, oxidative stress, and infection. In addition, all converge on the lysosomal pathway, wherein TFEB plays a key role as the major regulator of lysosomal biogenesis (and autophagy) [1, 2] .
Autophagy is particularly important in non-dividing neurons. Mice deficient in autophagy exhibit neuronal accumulation of aggregate-prone proteins and neurodegeneration, demonstrating the crucial role of autophagy in neuronal homeostasis [3, 4] . The role of the autophagy-lysosomal pathway (ALP) in neurodegenerative disease has been extensively studied in recent years, with defects in the pathway being strongly associated with disease [5] . In particular, late-onset neurodegenerative diseases such as PD, HD, and AD are characterized by the accumulation of intracellular aggregates in the brain, and clearance of these aggregates is typically associated with improvement of symptoms [6] . Thus, correcting ALP defects and enhancing the activity of the pathway are appealing therapeutic interventions. Since its discovery and characterization in Trends Recent work has continued to build on the importance of the ALP in the degradation of misfolded proteins that accumulate in many neurodegenerative diseases, and on elucidating further mechanisms of how disease features interact with the pathway.
Enhancing the ALP in neurodegenerative diseases continues to be a focal point of therapeutic development. In particular, TFEB has emerged as a potent activator of the ALP by coordinating autophagy induction with lysosomal biogenesis, and its activation has successfully ameliorated disease in mouse models of various neurodegenerative disorders.
Recent studies reveal that AD and PD exhibit a seeding and spreading phenomenon similar to that of prion disease. This phenomenon has driven the field to focus on the mechanics of seeding and spreading, and the role that autophagy may play.
